{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-23-081590","form_type":"8-K/A","ticker":"ADIL","cik":"0001513525","company_name":"ADIAL PHARMACEUTICALS, INC.","filed_at":"2023-10-30T23:59:59+00:00","discovered_at":"2026-05-14T18:03:29.323681+00:00","generated_at":"2026-06-09T05:52:46.341400+00:00","sec_items":["2.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"confidence":"high","headline":"Adial Pharmaceuticals amends 8-K to correct Purnovate sale closing date to August 17, 2023","bullets":["Corrected earliest event date from June 30 to August 17, 2023 for sale of Purnovate assets to Adovate.","Sale consideration included $450k upfront, 19.99% equity in Adovate, expense reimbursement, and milestone payments up to ~$11M (development/approval) and $50M (commercial).","No other changes to original 8-K; prior financial disclosures and terms remain unchanged."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-23-081590","json":"https://secwatch.observer/filing/0001213900-23-081590.json","markdown":"https://secwatch.observer/filing/0001213900-23-081590.md","text":"https://secwatch.observer/filing/0001213900-23-081590.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1513525/000121390023081590/0001213900-23-081590-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1513525/000121390023081590/ea187358-8ka1_adialphar.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-09T05:52:46.341400+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"87195a83de9eeda1ce4d605a30443c026a789512","claim":"ADIAL PHARMACEUTICALS, INC. completed a disposition involving Adovate, LLC (formerly known as Adenomed, LLC) (closed 2023-08-17).","evidence_excerpt":"On August 17, 2023, the Company completed the sale of the assets and business of Purnovate, Inc. (“Purnovate”) to Adovate, LLC (formerly known as Adenomed, LLC) (collectively, “Adovate”) under that certain Option Agreement for the Acquisition of Purnovate, Inc. by Adenomed, LLC, dated as of January 27, 2023","evidence_source":"SEC 8-K Item 2.01/5.01","evidence_url":"https://www.sec.gov/Archives/edgar/data/1513525/000121390023081590/0001213900-23-081590-index.htm","confidence":0.9,"family_label":"M&A Transactions","details":[{"label":"Action","value":"disposition"},{"label":"Counterparty","value":"Adovate, LLC (formerly known as Adenomed, LLC)"},{"label":"Closing","value":"2023-08-17"}],"fact_type":"ma_transaction"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}